EFG International’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Buy
40,543
+7,282
+22% +$895K 0.1% 174
2026
Q1
$3.92M Sell
33,261
-2,018
-6% -$282K 0.08% 220
2025
Q4
$5.78M Buy
+35,279
New +$5.53M 0.11% 154

Other funds holding RGEN

EFG International's RGEN Position: Q2 2026 in Review

EFG International increased its Repligen (RGEN) stake by 22% in Q2 2026, buying an estimated $895K and bringing the position to 40,543 shares worth $5.53M. The position accounts for 0.1% of the portfolio, ranked #174.

EFG International first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.78M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • EFG International held 40,543 shares of Repligen worth $5.53M as of Q2 2026.
  • EFG International bought 7,282 Repligen shares in Q2 2026, an estimated $895K.
  • Repligen made up 0.1% of EFG International's portfolio in Q2 2026, its #174 holding.
  • EFG International first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Repligen position peaked at $5.78M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.